Jaguar / Synexus [2016] IECompA m16020 (13 April 2016)

The Competition and Consumer Protection Commission found that the proposed acquisition would not substantially lessen competition in any market in Ireland and cleared the transaction.

Parties: Acquirer: Jaguar Holding Company I; Target: Synexus Clinical Research Topco Limited
Jurisdiction: Ireland
Judgment Date: 13 April 2016
Procedural Posture: Merger Control / Clearance (phase 1)
Outcome: cleared
Legal Topics: Merger Control, Acquisition, Sole Control

Competition Law Merger Control Acquisition Sole Control

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2

Parties

Jaguar Holding Company I

Acquirer

Synexus Clinical Research Topco Limited

Target

Procedural Posture

Merger Control / Clearance (phase 1)

Legal Issues

1 Whether the proposed acquisition would substantially lessen competition in any market in Ireland

Ratio Decidendi

The Competition and Consumer Protection Commission found that the proposed acquisition would not substantially lessen competition in any market in Ireland and cleared the transaction.

Court Disposition

cleared

Orders

The proposed acquisition by Jaguar Holding Company I of sole control of Synexus Clinical Research Topco Limited is cleared.